Annual Report 2008
Did the report help you?
Take survey (7 questions, 1 minute)

The changes in 2007 and 2008 were as follows:

 
 
2007
2008
 
 
 
Balance as of January 1:
 
 
Cost
3,853
4,249
Amortization / Impairments
(130)
(114)
Book value
3,723
4,135
 
 
 
Acquisitions
810
3,446
Impairments
(234)
Translation differences
(398)
354
 
 
 
Balance as of December 31:
 
 
Cost
4,249
8,033
Amortization / Impairments
(114)
(332)
 
 
 
Book value
4,135
7,701
 

Acquisitions in 2008 include the goodwill paid on the acquisition of Respironics for EUR 2,162 million, Genlyte for EUR 1,036 million, and VISICU for EUR 175 million, and several smaller acquisitions. Acquisitions in 2007 include the goodwill paid on the acquisition of Partners in Lighting for EUR 297 million, Color Kinetics for EUR 357 million and several smaller acquisitions. In addition, goodwill changed due to the finalization of purchase price accounting related to acquisitions in prior years.

A significant part of goodwill is allocated to the following reporting units:

 
 
2007
2008
 
 
 
Home Healthcare Solutions
388
2,800
Professional Luminaires
353
1,445
Imaging Systems
1,210
1,274
 

Home Healthcare Solutions and Professional Luminaires increased by the acquisitions of Respironics and Genlyte, respectively (see note 2) and are the most sensitive to fluctuations in the key assumptions used in the impairment tests as set out below.

The key assumptions used in the annual (performed in Q2) and trigger-based impairment tests were growth of sales and gross margin, together with the rates used for discounting the forecast cash flows. Sales and gross margin growth are based on management’s internal forecasts that cover an initial period of no more than five years and then are extrapolated with stable or declining growth rates, after which a terminal value is calculated for which growth rates are capped. The pre-tax discount rates are determined for each reporting unit (one level below sector level) and, in the annual test, ranged from 9.4% to 15.6%.

Due to deteriorating economic circumstances, and the decline of the market capitalization of the company, trigger-based impairment tests were performed in the latter half of the year using updated assumptions. The trigger-based tests resulted in goodwill impairment charges of EUR 234 million, mainly related to Lumileds as a consequence of weaker demand for LED solutions in the automotive, display and cell phone markets. The pre-tax discount rate used for the Lumileds impairment test was 14.6%.

Please refer to Information by sector and main country for a specification of goodwill by sector.

This is an interactive electronic version of the Philips Annual Report 2008 and also contains certain information in summarized form. The contents of this version are qualified in their entirety by reference to the printed version of the Philips Annual Report 2008. The printed version is available as a PDF file on this website. Information about: forward-looking statements, third-party market share data, fair value information, US GAAP basis of presentation, use of non-US GAAP information, statutory financial statements and management report, revision and reclassifications and analysis of 2007 compared to 2006.
158
159
Notes to the US GAAP financial statements
Notes to the IFRS financial statements
Notes to the Company financial statements
debugging messages